Ferritin and High Sensitivity C-Reactive Protein (hs-CRP) may predict the COVID-19 patient’s fate

Objective: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has rapidly spread worldwide. Clinical outcomes and severity are still unknown can be difficult to predict. In this study, we perform a cross-sectional observational study investigate the clinical characteristics of ferritin high sensitivity C-reactive protein status patients infected with COVID-19 that may predict patient’s fate. Methods: A total 106 (56 males 50 females, their ages ranging from 19 70 years) who were confirmed have real-time RT-PCR recruited in study. Blood samples withdrawn, biochemical tests (serum protein) performed. The gained data analyzed using GraphPad Prism software. Results: Overall, findings showed increased day 1 7 then decreased on 14 after diagnosis released full recovery. While they dramatically those moved intensive care unit or died 14. No gender-based differences noted. Conclusions: These suggest fate predicted at based these two biomarkers.